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Accepted 17 February 2012AbstractObjective: To present second-trimester ultrasound and molecular diagnosis for osteogenesis imperfecta (OI) type I in a female fetus and
incidental identification of a dominant COL1A1 deletion mutation in her paucisymptomatic father.
Case Report: A 30-year-old, primigravid woman was referred for genetic counseling in the second trimester because of bowing of the fetal lower
limbs. She and her husband were non-consanguineous, and there was no family history of skeletal dysplasias. Prenatal ultrasound at 22 weeks of
gestation revealed short and curved right femur and left tibia, and a short left fibula. The lengths of other long bones were normal. The husband
was 158 cm tall, had blue sclerae, a history of habitual subluxation and dislocation of bilateral elbows and left knee, and an episode of left ulna
fracture, and was not aware of his being affected with OI type I. The woman underwent amniocentesis. Cytogenetic analysis revealed
a karyotype of 46,XX. Molecular analysis of the amniocytes revealed a heterozygous deletion mutation of c.1064_1068delCTGGT in exon 17 of
the COL1A1 gene. By genetic testing the husband was found to carry the same mutation. Despite counseling of favorable outcome for OI type I
with the parents, the woman elected to terminate the pregnancy. Postnatal skeletal X-ray findings were consistent with OI type I.
Conclusion: Prenatal ultrasound diagnosis of mild forms of OI should include molecular analysis of type I collagen genes in both fetus and
parents. Molecular genetic analysis of the family may incidentally identify a collagen gene mutation in the paucisymptomatic affected parent.
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Osteogenesis imperfecta (OI) is a group of disorder that is
characterized by osteopenia, fractures, short statures, bone
deformity, blue sclerae, dentinogenesis imperfecta (DI),
progressive, postpubertal hearing loss, and hyperlaxity of
ligaments and skin [1,2]. The severity of OI varies in different
types ranging from perinatal lethality to individuals with short
stature, severe skeletal deformities and multiple fractures to
nearly asymptomatic individuals with normal stature, a mild
predisposition to fractures and normal life span [2]. OI type I
to type IV can be caused by mutations in COL1A1 or COL1A2
in an autosomal dominant pattern.
OI type II (OMIM 166210) is the most severe and perinatal
lethal form of OI that can be detected by ultrasound after 14
weeks of gestation with sonographic findings of hypominer-
alization, broad, crumpled and shortened limbs, thin beaded
ribs, bowing, angulation or fractures of the long bones,
abnormal calvarium and fractures, and clinical findings of
undermineralized skull, micromelia of long bones, beaded ribs
and severe bone deformity at birth [3]. OI type III (OMIM
259420) is a severe form of OI that can be detected by
ultrasound after 18 weeks of gestation with sonographic
findings of short limbs, hypomineralized skull, fractures and
decreased long bone lengths at 16e18 weeks of gestation, and
clinical findings of moderate limb deformity at birth, varied
scleral hue, very short stature and DI [3]. OI type IV (OMIM
166220) is a mild form of OI that can be rarely detected by
ultrasound after 20 weeks of gestation with sonographic
findings of long bone bowing and/or fractures on rareFig. 1. Prenatal ultrasound at 22 weeks of gestation shows: (A) curved left tibia and
femur; and (D) curved right femur. f ¼ fibula; t ¼ tibia.occasions and has clinical findings of normal sclerae, mild/
moderate limb deformity with fractures, variable short stature,
DI and some hearing loss [3]. OI type I (OMIM 166200) is the
mildest form of OI that can be rarely detected by ultrasound
after 20 weeks of gestation with sonographic findings of long
bone bowing or fractures in rare occasions and has clinical
findings of blue sclerae, normal stature, and fractures with
little or no limb deformity [3].
Herein we report our experience of prenatal ultrasound diag-
nosis and molecular analysis of OI type I in the second trimester
in a female fetus and incidental identification of a dominant
COL1A1 deletion mutation in her paucisymptomatic father.
Case report
A 30-year-old, primigravid woman was referred to the
hospital at 22 weeks of gestation because of bowing of the
lower limbs in the fetus. Her husband was 31 years old. She
and her husband were non-consanguineous, and there was no
family history of skeletal dysplasias. Prenatal ultrasound at 22
weeks of gestation revealed a normal amount of amniotic
fluid, a short and curved right femur, a short and curved left
tibia, and a short left fibula (Fig. 1). The biparietal diameter,
abdominal circumference and the lengths of humerus, radius
and ulna were equivalent to 22 weeks. The right femur, tibia,
fibula, humerus, radius and ulna were measured 3.97 cm (<
mean-2 standard deviation, SD), 3.97 cm, 3.69 cm, 4.16 cm,
3.46 cm and 3.92 cm, respectively, and the left femur, tibia,
fibula, humerus, radius and ulna were measured 4.51 cm,
3.50 cm (< mean-2SD), 3.47 cm (< mean-2SD), 4.31 cm,straight left fibula; (B) curved left tibia; (C) straight left femur and curved right
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type I was tentatively diagnosed. Genetic counseling of the
parents revealed that the mother was 165 cm tall, and the
father was 158 cm tall. The couple denied any family history
of OI. The mother was completely normal. The father was
found to have bilateral blue sclerae, a history of habitual
subluxation and dislocation of bilateral elbows and left knee,
and an episode of left ulna fracture with no bone deformity.
The father was paucisymptomatic and was not aware of his
being affected with a mild form of OI type I. The woman
underwent amniocentesis at 22 weeks of gestation. Cytoge-
netic analysis revealed a karyotype of 46,XX. Molecular
analyses of the amniocytes revealed a heterozygous deletion
mutation c.1064_1068delCTGGT in exon 17 of the COL1A1
gene resulting in a functional null allele (Fig. 2). The mutation
caused a frameshift, introducing 6 novel residues at codon 356
and resulting in a premature termination codon (p.G356PfsX7)Fig. 2. Molecular analysis of the COL1A1 gene shows a heterozygous deletion
mutation of c.1064_1068delCTGGT in exon 17 in the fetus and the father. The
mother was normal.that removed all the following amino acids of the protein.
Molecular analyses of the parental blood also showed that the
father carried the same mutation (Fig. 2). Despite counseling
of favorable outcome of OI type I with the parents, the mother
elected to terminate the pregnancy. Postnatal radiograph
demonstrated mildly curved lower limbs in the fetus (Fig. 3).
Discussion
Individuals with OI types II, III and IV generally have
structural abnormalities within the triple helix of the type I
collagen because of point mutations, insertions, deletions or
splice site mutations in either COL1A1 or COL1A2. However,
individuals with OI type I usually have decreased synthesis of
the structurally normal type I collagen because of a COL1A1
null allele resulted from mutations within COL1A1 [4e7].
Mutations that may produce a COL1A1 null allele include
mutations of nonsense, deletions and insertions resulting in
a premature stop codon, and mutations of splicing site inter-
fering normal splicing of the COL1A1 gene [6,8,9]. The
present case had a small deletion within the exon 17 of
COL1A1 that causes a frameshift and a premature stop codon,
and creates a COL1A1 null allele. It has been suggested that
nonsense and frameshift mutations throughout most of the
COL1A1 gene will result in a “functional null” allele (null
allele), which is associated with a mild form of OI type I
[5e9]. Such a mutation will lead to both marked reduction in
steady-state level of mRNA from the mutant allele and
a quantitative decrease in type I procollagen production [6].Fig. 3. Postnatal radiograph shows mildly curved lower limbs.
279C.-P. Chen et al. / Taiwanese Journal of Obstetrics & Gynecology 51 (2012) 276e279OI type I is very difficult to identify by fetal ultrasound
because in OI type I, the limb length is almost always normal,
and femur bowing is only rarely apparent after 20 weeks of
gestation. Therefore, prenatal molecular diagnosis of OI type I
in pregnancies at risk for OI type I may be required. Pepin et al
[10] first detected one affected fetus and one normal fetus in
two pregnancies at risk for OI type I using molecular tech-
niques instead of biochemical analysis. Pepin et al [10] found
that biochemical analysis for OI type I using cultured cho-
rionic villus sampling (CVS) cells is not reliable, and sug-
gested that prenatal diagnosis of OI type I should be limited to
molecular diagnosis. Nuytinck et al [11] used COL1A1 null-
allele testing for rapid prenatal diagnosis in a pregnancy
with maternal OI type I and found that the fetus would not be
affected with OI by the finding that the fetus had inherited
a normal COL1A1 allele in the affected mother. Ries et al [12]
reported prenatal molecular diagnosis of R848X in the
COL1A1 gene by CVS in a pregnancy with paternal OI type I.
The father was 163 cm tall and had blue sclerae and shortening
of the right leg due to poorly healed fracture and osteopenia.
The parents elected to carry the pregnancy to term. The
affected baby was delivered with a fractured clavicle, bowed
right tibia and blue sclerae but had a favorable outcome.
Robyr et al [13] reported three cases of prenatally detected
OI with bowed long bones and/or micromelia, and all were
associated with paucisymptomatic fathers unaware of the
disorder. In the first case, the father had repetitive endorses,
marked ligmentous laxity and macrocephaly. In the second
case, the father had repetitive endorses and fractures, and
unilateral deafness. In the third case, the father had genu
varum and kyphscoliosis. Of the three pregnancies, two were
terminated, and only one was carried to full term. In a study of
19 cases with OI type I, 10 cases with OI type III and 19 cases
with OI type IV, Lin et al [14] found that 84.2% (16/19) of
type I patients had a family history of OI compared with none
in type III and 36.8% (7/19) in type IV. Since OI type I has the
mildest phenotype and the lowest incidence of decreased
height, weight and bone mineral density, hearing loss, bone
deformity, fractures and walking disability [14], it is very
probable that some adults who are affected with OI type I may
be unaware of the disorder during genetic counseling.
In conclusion, a fetus with OI may give the first insight into
a familial autosomal dominant disorder undiscovered in the
parent. We suggest that prenatal ultrasound diagnosis of mild
forms of OI should include molecular analysis of type I
collagen genes in both fetus and parents. Molecular genetic
analysis of the family may incidentally identify a collagen
gene mutation in the paucisymptomatic affected parent. The
information acquired is helpful for genetic counseling and
perinatal management.Acknowledgments
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